Crystalline form of a quinolinone-carboxamide compound

Details for Australian Patent Application No. 2006232129 (hide)

Owner Theravance, Inc.

Inventors Genov, Daniel; Goldblum, Adam; Fatheree, Paul R.; Chao, Robert; Turner, S. Derek

Agent Davies Collison Cave

Pub. Number AU-B-2006232129

PCT Pub. Number WO2006/108127

Priority 60/668,780 06.04.05 US

Filing date 5 April 2006

Wipo publication date 12 October 2006

Acceptance publication date 12 July 2012

International Classifications

C07D 451/04 Heterocyclic compounds containing condensed hetero ring systems

A61K 31/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/108127 Priority application(s): WO2006/108127

12 July 2012 Application Accepted

  Published as AU-B-2006232129

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006232130-Ocular delivery of interferon-tau

2006232128-Dispenser for razor cartridges